Bank of Montreal Can Lowers Stock Holdings in STERIS plc (NYSE:STE)

Bank of Montreal Can cut its stake in shares of STERIS plc (NYSE:STE - Free Report) by 2.4% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 91,861 shares of the medical equipment provider's stock after selling 2,297 shares during the period. Bank of Montreal Can owned about 0.09% of STERIS worth $18,883,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Avalon Trust Co acquired a new stake in STERIS in the 4th quarter worth about $30,000. Human Investing LLC acquired a new stake in STERIS during the 4th quarter worth $31,000. Anfield Capital Management LLC grew its holdings in shares of STERIS by 100.0% during the fourth quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider's stock worth $37,000 after buying an additional 91 shares in the last quarter. Central Pacific Bank Trust Division lifted its stake in shares of STERIS by 65.5% in the fourth quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider's stock worth $39,000 after buying an additional 76 shares in the last quarter. Finally, Manchester Capital Management LLC lifted its stake in shares of STERIS by 182.7% in the fourth quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider's stock worth $44,000 after buying an additional 137 shares in the last quarter. Institutional investors and hedge funds own 94.69% of the company's stock.

STERIS Trading Up 1.5 %

NYSE STE traded up $3.29 on Thursday, reaching $223.31. The stock had a trading volume of 104,758 shares, compared to its average volume of 529,294. STERIS plc has a 12-month low of $197.82 and a 12-month high of $248.24. The company has a quick ratio of 1.40, a current ratio of 2.13 and a debt-to-equity ratio of 0.32. The stock has a fifty day moving average price of $222.53 and a two-hundred day moving average price of $219.42. The firm has a market capitalization of $21.94 billion, a price-to-earnings ratio of 47.37 and a beta of 0.87.

STERIS (NYSE:STE - Get Free Report) last issued its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. As a group, sell-side analysts forecast that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, March 21st. Stockholders of record on Thursday, February 20th were issued a $0.57 dividend. The ex-dividend date of this dividend was Thursday, February 20th. This represents a $2.28 dividend on an annualized basis and a dividend yield of 1.02%. STERIS's payout ratio is 48.41%.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on STE shares. Needham & Company LLC restated a "hold" rating on shares of STERIS in a report on Monday, April 7th. JMP Securities reiterated a "market outperform" rating and set a $265.00 price target on shares of STERIS in a report on Thursday, April 10th. Stephens reissued an "overweight" rating and issued a $240.00 price objective on shares of STERIS in a report on Thursday, February 6th. Finally, Piper Sandler boosted their target price on shares of STERIS from $260.00 to $265.00 and gave the company an "overweight" rating in a report on Monday, February 3rd. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $258.75.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.